Published in PLoS One on May 23, 2014
Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations. J Clin Endocrinol Metab (2015) 0.89
A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability. Oncotarget (2016) 0.84
Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells. Int J Mol Sci (2016) 0.78
MicroRNA‑20a promotes the proliferation and cell cycle of human osteosarcoma cells by suppressing early growth response 2 expression. Mol Med Rep (2015) 0.78
microRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer. Oncotarget (2016) 0.78
The role of microRNAs in gallbladder cancer. Mol Clin Oncol (2016) 0.77
Low-Dose Endothelial-Monocyte-Activating Polypeptide-II Induced Autophagy by Down-Regulating miR-20a in U-87 and U-251 Glioma Cells. Front Cell Neurosci (2016) 0.77
p21 participates in the regulation of anaplastic thyroid cancer cell proliferation by miR-146b. Oncol Lett (2016) 0.77
Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma. Int J Clin Exp Pathol (2015) 0.76
miRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancers. Oncotarget (2016) 0.75
Down-regulation of miR-20a-5p triggers cell apoptosis to facilitate mycobacterial clearance through targeting JNK2 in human macrophages. Cell Cycle (2016) 0.75
miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8. Onco Targets Ther (2017) 0.75
Restoration of miR-20a expression suppresses cell proliferation, migration, and invasion in HepG2 cells. Onco Targets Ther (2016) 0.75
Oncogenic role of microRNA‑20a in human uveal melanoma. Mol Med Rep (2016) 0.75
Oncogenic role of microRNA-20a in human multiple myeloma. Onco Targets Ther (2017) 0.75
Genistein up-regulates miR-20a to disrupt spermatogenesis via targeting Limk1. Oncotarget (2017) 0.75
Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer (2006) 46.47
A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21
c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 31.81
The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet (2010) 15.87
The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A (2005) 8.60
Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab (2008) 5.94
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
MiRNAs and cancer. Am J Pathol (2009) 3.42
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene (2007) 3.29
A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol (2008) 3.02
MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat Cell Biol (2009) 2.49
Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Sci (2008) 2.39
The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol (2008) 2.29
LIM kinases: function, regulation and association with human disease. J Mol Med (Berl) (2007) 2.26
Lim kinases, regulators of actin dynamics. Int J Biochem Cell Biol (2006) 2.14
A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab (2006) 2.10
miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res (2011) 2.06
A role for LIM kinase in cancer invasion. Proc Natl Acad Sci U S A (2003) 2.03
microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci U S A (2010) 1.97
The effect of central loops in miRNA:MRE duplexes on the efficiency of miRNA-mediated gene regulation. PLoS One (2008) 1.78
LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem (2003) 1.66
miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-Cadherin distribution. Dev Biol (2009) 1.56
Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. Thyroid (2009) 1.41
LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system. Int J Cancer (2006) 1.34
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia. Clin Cancer Res (2013) 1.30
miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells. FEBS Lett (2012) 1.16
Nischarin inhibits LIM kinase to regulate cofilin phosphorylation and cell invasion. Mol Cell Biol (2008) 1.14
miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim Biophys Sin (Shanghai) (2010) 1.13
Expression of LIM kinase 1 is associated with reversible G1/S phase arrest, chromosomal instability and prostate cancer. Mol Cancer (2007) 1.12
Establishment of a highly differentiated thyroid cancer cell line of Hürthle cell origin. Thyroid (1998) 0.98
Hereditary non-medullary thyroid cancer. World J Surg (2008) 0.97
MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer. PLoS One (2011) 0.94
Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model. Biomaterials (2013) 0.93